Sign in or register to see full information and data.

Studies / CAVD 460


Study information

Grant Affiliation:Picker: An Attenuated CMV Vector
Strategy:Vector vaccines (viral or bacterial)
Study Type:Pre-Clinical NHP
Species:Rhesus macaque
Stage:Assays Completed
Study Start Date:2014-09-09
Study Made Public:2017-02-08


Humoral response in an NHP vaccination model using RhCMV/SIV followed by homologous or heterologous challenge


CAVD 460 is a non-human primate challenge study to compare immunogenicity and protection following administration with CMV/SIV vector immunogens, delta-pp71 RhCMV/SIVmac239 versus delta-pp71 RhCMV/SIVsmE660.


SIVmac239 delta-pp71 RhCMV/SIVmac239 delta-pp71 RhCMV/SIVsmE660

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.